Indofarma Lays Off Hundreds of Employees, Guarantees Workers’ Rights Are Fulfilled

November 10, 2025
5:23 PM

Jakarta, hitclubapk3 Indonesia
—
PT
Indofarma
Tbk (INAF) provided a related explanation
termination of employment
(
Layoffs
) to 413 employees.
Through the IDX Information Disclosure document, Indofarma said that this step was taken to restructure the company.
“This draft Restructuring Plan is part of the implementation of the Corporate Restructuring Strategy through financial restructuring and business reorientation, as well as following up on the peace agreement (homologation) in the Postponement of Debt Payment Obligations (PKPU), in accordance with Peace Decision Number 74/PDT.SUS-PKPU/2024/PN.NIAGA.JKT.PST dated August 15 2024,” said Indofarma management in Information Disclosure, Monday(10/11).
ADVERTISEMENT
SCROLL TO CONTINUE WITH CONTENT
Indofarma explained that it had received funding support to support the implementation of operational cost efficiencies as stipulated in the homologation decision.This has been conveyed through information disclosure to the Financial Services Authority (OJK) on September 17 2025.
The company ensures that efficiency is carried out as a whole for various components of operational costs that are not yet optimal, with the aim of increasing productivity and maintaining business sustainability.
Indofarma makes organizational adjustments according to the business model it will run, so that operational activities can take place more effectively and efficiently.
“With this funding support, Indofarma ensures that all obligations related to employee rights are completed in accordance with applicable regulations,” said Indofarma management.
The news that Infofarma had laid off hundreds of employees was known through the financial report for the third quarter of 2025.
“On September 15 2025 the company has implemented
rightsizing
“to employees with a total of 413 people, so practically as of September 15 2025 the number of employees is 3 people,” wrote Indofarma management in an information disclosure, last Friday (31/10).
In this statement, Indofarma explained that it had recruited 18 new employees.Thus, they currently have 21 employees.
Indofarma explained that the addition of employees will be adjusted to the needs of Human Resources (HR) to run a limited business model, in accordance with the Homologation Decision.
On September 15 2025, Indofarma received a loan from the state-owned pharmaceutical holding, PT Bio Farma, amounting to IDR 220 billion.The debt is used to support the company’s operational cost efficiency.
Based on the homologation decision, Indofarma must prioritize operational cost efficiency, which includes all inefficient and productive operating cost components to reduce operational costs and increase profitability.The loan has a term of 12 months, with interest of 7 percent.
In connection with the loan agreement, Indofarma will provide collateral in the form of the company’s non-guaranteed assets in 18 locations.This guarantee is provided after Indofarma obtains approval from the General Meeting of Shareholders in accordance with statutory provisions.
[Gambas:hitclubapk3 Video]
(dhf/sfr)